Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/54325
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bartlewski, P. M. | |
dc.contributor.author | Aravindakshan, J. | |
dc.contributor.author | Beard, A. P. | |
dc.contributor.author | Nelson, M. L. | |
dc.contributor.author | Batista-Arteaga, M. | |
dc.contributor.author | Cook, S. J. | |
dc.contributor.author | Rawlings, N. C. | |
dc.date.accessioned | 2019-02-18T10:05:17Z | - |
dc.date.available | 2019-02-18T10:05:17Z | - |
dc.date.issued | 2004 | |
dc.identifier.issn | 0378-4320 | |
dc.identifier.uri | http://hdl.handle.net/10553/54325 | - |
dc.description.abstract | When ovulation is induced with gonadotrophin-releasing hormone (GnRH) in anoestrous ewes, a proportion of animals fail to form normal (full-lifespan) corpora lutea (CL). Progesterone treatment before GnRH prevents luteal inadequacy. It remains uncertain whether a similar effect, achieved with medroxyprogesterone acetate (MAP) from intravaginal sponges, is mediated by influences on growing ovarian follicles and/or secretion of gonadotrophic hormones, before and after GnRH treatment. Two experiments were performed, on 13 and 11 anoestrous Western white-faced ewes, respectively. Seven and six ewes, respectively, received MAP-containing sponges (60mg) for 14 days; the remaining ewes served as untreated controls. To test the effect of timing of GnRH administration after pre-treatment with MAP-releasing sponges, GnRH injections (250ng every 2h for 24h followed by a bolus injection of 125μg of GnRH i.v.) were given either immediately (Experiment 1) or 24h after sponge removal in the treated ewes (Experiment 2). Ovarian follicular dynamics (follicles reaching ≥5mm in size) and development of luteal structures were monitored using transrectal ultrasonography. In Experiment 1, the mean ovulation rate (0.7±0.3 and 1.0±0.4) and proportion of ovulating ewes (57 and 67%, respectively) did not vary (P>0.05) between MAP-treated and control ewes. Normal (full-lifespan) CL were detected in 29% of treated and 67% of control ewes (P>0.05). In Experiment 2, the mean ovulation rate (2.3±0.2 and 1.2±0.6; P<0.05) and percentage of ewes with normal (full-lifespan) CL (100 and 40%, respectively; P<0.10) were greater in the treated compared to control ewes. In Experiment 1, the mean peak concentration of the GnRH-induced LH surge was lower (P<0.05) in MAP-treated than in control ewes. There were no significant differences between MAP-treated and control ewes in the characteristics of follicular waves, mean daily serum FSH concentrations, and secretory parameters of LH/FSH, based on intensive blood sampling conducted 1 day before sponging and 1 day before sponge removal. It is concluded that treatment with MAP has no effect on the tonic secretion of LH/FSH or follicular wave development in anoestrous ewes. However, the GnRH-stimulated LH discharge was attenuated in the ewes that received MAP-impregnated sponges for 14 days and were treated with GnRH immediately after sponge withdrawal. Ovulatory response and CL formation were increased when GnRH was administered 24h after sponge removal. © 2003 Elsevier B.V. All rights reserved. | |
dc.publisher | 0378-4320 | |
dc.relation.ispartof | Animal Reproduction Science | |
dc.source | Animal Reproduction Science[ISSN 0378-4320],v. 81, p. 63-75 | |
dc.title | Effects of medroxyprogesterone acetate (MAP) on ovarian antral follicle development, gonadotrophin secretion and response to ovulation induction with gonadotrophin-releasing hormone (GnRH) in seasonally anoestrous ewes | |
dc.type | info:eu-repo/semantics/Article | |
dc.type | Article | |
dc.identifier.doi | 10.1016/j.anireprosci.2003.10.002 | |
dc.identifier.scopus | 1142265911 | |
dc.contributor.authorscopusid | 6701851423 | |
dc.contributor.authorscopusid | 6507505319 | |
dc.contributor.authorscopusid | 7004524599 | |
dc.contributor.authorscopusid | 57198484703 | |
dc.contributor.authorscopusid | 6506315360 | |
dc.contributor.authorscopusid | 8975211100 | |
dc.contributor.authorscopusid | 7005301556 | |
dc.description.lastpage | 75 | |
dc.description.firstpage | 63 | |
dc.relation.volume | 81 | |
dc.type2 | Artículo | |
dc.date.coverdate | Enero 2004 | |
dc.identifier.ulpgc | Sí | es |
dc.description.jcr | 1,41 | |
dc.description.jcrq | Q1 | |
dc.description.scie | SCIE | |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR IUIBS: Medicina Veterinaria e Investigación Terapéutica | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Patología Animal, Producción Animal, Bromatología y Tecnología de Los Alimentos | - |
crisitem.author.orcid | 0000-0001-9753-4786 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Batista Arteaga, Miguel | - |
Appears in Collections: | Artículos |
SCOPUSTM
Citations
18
checked on Nov 17, 2024
WEB OF SCIENCETM
Citations
16
checked on Nov 17, 2024
Page view(s)
102
checked on Sep 13, 2024
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.